Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients

BACKGROUND/AIMS: Studies of hepatic steatosis (HS) effect on COVID-19 vaccine immunogenicity are lacking. We aimed to compare immunogenicity of BNT162b2 and CoronaVac among moderate/severe HS and control subjects. METHODS: Two hundred ninety-five subjects who received BNT162b2 or CoronaVac vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheung, Ka Shing, Lam, Lok Ka, Hui, Rex Wan Hin, Mao, Xianhua, Zhang, Ruiqi R, Chan, Kwok Hung, Hung, Ivan FN, Seto, Wai Kay, Yuen, Man-Fung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293606/
https://www.ncbi.nlm.nih.gov/pubmed/35545127
http://dx.doi.org/10.3350/cmh.2022.0082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293606/
https://www.ncbi.nlm.nih.gov/pubmed/35545127
http://dx.doi.org/10.3350/cmh.2022.0082

Ejemplares similares